SHIELD THERAPEUTICS PLC
Get an alert when SHIELD THERAPEUTICS PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£8.7M
USD 11,621,000
+78.1% vs 2024
Net assets
-£11M
USD -15,077,000
-1,044.8% lowest in 3 filed years
Employees
68
-11.7% lowest in 3 filed years
Profit before tax
-£13M
USD -17,141,000
+35.5% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £9,795,628 | £24,090,433 | £37,206,917 | +54.4% | |
| Operating profit | -£23,454,859 | -£17,123,072 | -£7,523,581 | +56.1% | |
| Profit before tax | -£24,236,413 | -£19,880,222 | -£12,832,011 | +35.5% | |
| Net profit | -£24,923,641 | -£20,348,855 | -£13,216,799 | +35% | |
| Cash | £10,441,683 | £4,883,965 | £8,699,656 | +78.1% | |
| Total assets less current liabilities | — | £3,979,638 | -£3,699,656 | -193% | |
| Net assets | £11,253,930 | -£985,926 | -£11,286,869 | -1,044.8% | |
| Equity | £11,253,930 | -£985,926 | -£11,286,869 | -1,044.8% | |
| Average employees | 73 | 77 | 68 | -11.7% | |
| Wages | £8,966,163 | £8,952,688 | £10,295,703 | +15% | |
| Directors' remuneration | £974,697 | £3,442,132 | £2,961,521 | -14% |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | — | -71.1% | -20.2% | |
| Net margin | — | -84.5% | -35.5% | |
| Return on capital employed | — | -430.3% | — | |
| Gearing (liabilities / total assets) | 69.2% | 102.3% | 123.1% | |
| Current ratio | 2.28x | 1.16x | 1.21x | |
| Interest cover | -20.06x | -5.79x | -1.35x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the above factors, the Directors believe that it remains appropriate to prepare the financial statements on a going concern basis.”
Group structure
- SHIELD THERAPEUTICS PLC · parent
- Phosphate Therapeutics Limited 100%
- Shield TX (Switzerland) AG 100%
- Shield Therapeutics Inc 100%
- Shield TX (UK) Limited 100%
Significant events
- “On 30 January 2026, the Group agreed updated terms with its Chinese partner, Beijing Aosaikang Pharmaceutical Co. Ltd ("ASK"), under which ASK will pay a development milestone of $7.9 million to the Group following ASK's planned Q1 2026 submission for marketing authorisation of ACCRUFER in China.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUNTINGTON-BAILEY, Lucy Kate | Secretary | 2017-09-01 | — | — |
| HASLER, Hans Peter | Director | 2018-07-26 | Feb 1956 | Swiss |
| LACERCA-ALLEN, Maria Fabiana | Director | 2021-05-10 | Apr 1967 | Argentine,American |
| LLEWELLYN-DAVIES, Peter | Director | 2016-02-26 | Apr 1958 | British |
| LUNDSTROM, Karl Anders | Director | 2021-05-10 | May 1962 | Swedish,American |
| SCHWEIGER, Christian Karl Kurt, Dr | Director | 2020-06-26 | Jul 1966 | German,Swiss |
| WIDMANN, Rudolf Stefan, Dr | Director | 2024-07-03 | Mar 1957 | Austrian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JONES, Richard | Secretary | 2015-09-03 | 2017-01-27 |
| CAPITA REGISTRARS LIMITED | Corporate Secretary | 2017-01-27 | 2017-09-01 |
| ESTELL, Joanne Elizabeth | Director | 2017-05-01 | 2017-09-14 |
| HEATH, Andrew John William | Director | 2016-02-26 | 2018-06-27 |
| HOFFMANN, Rolf Karl Heinz | Director | 2018-04-06 | 2021-06-17 |
| JONES, Richard Crispin Morgan | Director | 2015-09-03 | 2017-01-27 |
| KARIS, James | Director | 2016-02-26 | 2020-06-18 |
| MADISON, Gregory Paul | Director | 2021-06-18 | 2024-07-24 |
| STERRITT, Carl Andrew | Director | 2015-09-03 | 2020-04-21 |
| WATTS, Tim William | Director | 2020-04-27 | 2021-09-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Aop Health International Management Ag | Corporate entity | Shares 25–50%, Voting 25–50% | 2022-08-01 | Active |
| Nestle Sa | Corporate entity | Shares 25–50%, Voting 25–50% | 2017-06-26 | Ceased 2022-09-01 |
Filing timeline
Last 20 of 126 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-06-12 RESOLUTIONS Resolution
- 2025-01-06 RESOLUTIONS Resolution
- 2024-06-27 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-29 | AA | accounts | Accounts with accounts type group | |
| 2026-05-28 | SH01 | capital | Capital allotment shares | |
| 2026-02-20 | SH01 | capital | Capital allotment shares | |
| 2026-01-29 | SH01 | capital | Capital allotment shares | |
| 2026-01-27 | SH01 | capital | Capital allotment shares | |
| 2025-12-17 | SH01 | capital | Capital allotment shares | |
| 2025-09-26 | SH01 | capital | Capital allotment shares | |
| 2025-09-26 | SH01 | capital | Capital allotment shares | |
| 2025-09-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-12 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-06 | AA | accounts | Accounts with accounts type group | |
| 2025-01-06 | RESOLUTIONS | resolution | Resolution | |
| 2025-01-02 | SH01 | capital | Capital allotment shares | |
| 2024-09-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-06-17 | AA | accounts | Accounts with accounts type group | |
| 2023-10-20 | SH01 | capital | Capital allotment shares | |
| 2023-10-09 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 8
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.